Addex Therapeutics Ltd (ADXN)
11.10
+0.40
(+3.74%)
USD |
NASDAQ |
Nov 04, 13:24
Addex Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -1.32K% |
| December 31, 2023 | -1.86K% |
| September 30, 2023 | -798.5% |
| June 30, 2023 | -424.0% |
| March 31, 2023 | -480.6% |
| December 31, 2022 | -616.4% |
| September 30, 2022 | -1.00K% |
| June 30, 2022 | -3.94K% |
| March 31, 2022 | -2.45K% |
| December 31, 2021 | -1.11K% |
| September 30, 2021 | -527.6% |
| Date | Value |
|---|---|
| June 30, 2021 | -472.5% |
| March 31, 2021 | -312.7% |
| December 31, 2020 | -116.7% |
| September 30, 2020 | -12.15K% |
| June 30, 2020 | -361.8% |
| March 31, 2020 | -476.3% |
| December 31, 2019 | -351.4% |
| September 30, 2019 | -713.7% |
| June 30, 2019 | -866.3% |
| March 31, 2019 | -433.9% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-12.15K%
Minimum
Sep 2020
-116.7%
Maximum
Dec 2020
-1.60K%
Average
-572.0%
Median
Profit Margin (Quarterly) Benchmarks
| AC Immune SA | -3.31K% |
| CRISPR Therapeutics AG | -- |
| NLS Pharmaceutics Ltd | -- |
| Molecular Partners AG | -972.4% |
| MoonLake Immunotherapeutics | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 90.28% |
| Return on Assets | 54.90% |
| Return on Invested Capital | 90.28% |
| Operating Margin (Quarterly) | -780.1% |
| Return on Net Operating Assets | 74.93% |